RadNet (NasdaqGM:RDNT) Q4 2025 Earnings call March 02, 2026 10:30 AM ET Company ParticipantsAndrew Mok - DirectorHoward Berger - President and CEOKees Wesdorp - President and CEO of Digital HealthLarry Solow - Managing DirectorMark Stolper - EVP and CFOSham Sokka - COO and CTO of Digital HealthYuan Zhi - Managing DirectorConference Call ParticipantsBrian Tanquilut - Senior Healthcare Services AnalystDavid MacDonald - Managing Director and Senior Equity Research AnalystJim Sidoti - AnalystMatthew Gillmor - D ...

RadNet (NasdaqGM:RDNT) Q4 2025 Earnings call March 02, 2026 10:30 AM ET Company ParticipantsAndrew Mok - DirectorHoward Berger - President and CEOKees Wesdorp - President and CEO of Digital HealthLarry Solow - Managing DirectorMark Stolper - EVP and CFOSham Sokka - COO and CTO of Digital HealthYuan Zhi - Managing DirectorConference Call ParticipantsBrian Tanquilut - Senior Healthcare Services AnalystDavid MacDonald - Managing Director and Senior Equity Research AnalystJim Sidoti - AnalystMatthew Gillmor - D ...

RadNet (NasdaqGM:RDNT) Q4 2025 Earnings call March 02, 2026 10:30 AM ET Speaker10Good day, welcome to the RadNet Fourth Quarter 2025 financial results conference call. All participants will be in a listen only mode. Should you need assistance, please signal conference specialist by pressing the Star key followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press Star then 1 on your touch tone phone. To withdraw your question, please press Star t ...

Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 48.2% to $27.9 million in the fourth quarter of 2025 from $18.9 million in the fourth quarter of 2024Total Company Adjusted EBITDA(1) was a quarterly record of $87.7 million in the fourth quarter of 2025 as compared with $75.0 million in the fourth quarter ...

Financial Performance & Growth - RadNet's Q3 2025 revenue increased by 13.4% compared to Q3 2024, achieving record quarterly revenue[22] - The company's adjusted EBITDA margin increased by 26 basis points to 16.2%[20] - RadNet has a strong liquidity position with $804.7 million in cash balance and a net debt to adjusted EBITDA leverage ratio of approximately 1.0x[22] - The company anticipates a revenue CAGR of +11% to +13% and a Digital Health revenue CAGR of ~30% from 2025 to 2028[788] Procedural Volume Growth - MRI procedural volume grew by 14.8% in aggregate and 11.5% on a same-center basis[21] - CT procedural volume increased by 9.4% in aggregate and 6.7% on a same-center basis[21] - PET/CT procedural volume experienced a significant increase of 21.1% in aggregate and 14.9% on a same-center basis[21] Technology & Innovation - Deep Learning Reconstruction (DLR) allows for 50-75% faster MRIs while improving image quality[43] - RadNet performs over 2 million mammograms a year, representing 5% of all mammograms in the US[283] - AI-assisted reads found clinically significant prostate cancer in 24% of men when MRI was deemed negative by the radiologist[343] Market Trends & Opportunities - The national imaging market is estimated at $100 billion in 2025[568] - The company's joint venture revenue is projected to reach ~$800 million in 2025, reflecting a CAGR of 19.1% from 2022 to 2025[607] - The company has seen ~18x increase in Cardiac CTA volume from Jan 2020 to October 2025[506]